Arax Advisory Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$964K Buy
15,067
+13,022
+637% +$856K 0.01% 1237
2026
Q1
$141K Sell
2,045
-1,666
-45% -$131K ﹤0.01% 1230
2025
Q4
$304K Sell
3,711
-6,031
-62% -$470K 0.01% 820
2025
Q3
$732K Buy
9,742
+6,943
+248% +$518K 0.01% 764
2025
Q2
$207K Sell
2,799
-555
-17% -$38.6K 0.01% 639
2025
Q1
$271K Buy
3,354
+1,752
+109% +$151K 0.02% 452
2024
Q4
$125K Buy
1,602
+175
+12% +$14.9K 0.01% 606
2024
Q3
$134K Buy
1,427
+34
+2% +$2.85K 0.01% 434
2024
Q2
$109K Buy
1,393
+246
+21% +$20.1K 0.01% 456
2024
Q1
$104K Hold
1,147
0.01% 383
2023
Q4
$88.7K Hold
1,147
0.01% 397
2023
Q3
$78K Buy
1,147
+1
+0.1% +$73 0.01% 391
2023
Q2
$93.1K Sell
1,146
-9
-0.8% -$718 0.01% 358
2023
Q1
$94.7K Buy
+1,155
New +$82.5K 0.01% 356

Other funds holding GEHC

Arax Advisory Partners's GEHC Position: Q2 2026 in Review

Arax Advisory Partners increased its GE HealthCare (GEHC) stake by 637% in Q2 2026, buying an estimated $856K and bringing the position to 15,067 shares worth $964K. The position accounts for 0.01% of the portfolio, ranked #1237.

Arax Advisory Partners first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Arax Advisory Partners held 15,067 shares of GE HealthCare worth $964K as of Q2 2026.
  • Arax Advisory Partners bought 13,022 GE HealthCare shares in Q2 2026, an estimated $856K.
  • GE HealthCare made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1237 holding.
  • Arax Advisory Partners first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.